Expertise in
10
conditions

Dr. Sardar Z. Imam

Hematology
San Juan Oncology Associates PC
2325 E 30th St, 
Farmington, NM 
Accepting New Patients
Expertise in
10
conditions
San Juan Oncology Associates PC
2325 E 30th St, 
Farmington, NM 

Overview

Sardar Imam is a Hematologist practicing medicine in Farmington, New Mexico.

Dr. Imam is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Lung Nodules, Multiple Myeloma, Muscle Invasive Bladder Cancer, Thrombocytopenia, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 5 clinical trials. Dr. Imam is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in NM

Hospital Affiliations

San Juan Regional Medical Center Inc
Mercy Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Rocky Mountain Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Sky Community Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER COMMERCIAL
View 10 Less Insurance Carriers -

Locations

San Juan Oncology Associates PC
2325 E 30th St, Farmington, NM 87401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Enrollment Status: Active_not_recruiting
Publish Date: August 25, 2026
Intervention Type: Biological
Study Drug: Dostarlimab
Study Phase: Phase 1
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (AMBER)
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (AMBER)
Enrollment Status: Active_not_recruiting
Publish Date: October 28, 2025
Intervention Type: Drug
Study Drugs: TSR-022, Nivolumab, TSR-042, TSR-033, Docetaxel
Study Phase: Phase 1
Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for Unresectable Locally Advanced or Metastatic Solid Tumors
Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for Unresectable Locally Advanced or Metastatic Solid Tumors
Enrollment Status: Terminated
Publish Date: March 10, 2025
Intervention Type: Drug
Study Drug: Ladiratuzumab Vedotin
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination With Cabozantinib (CB-Cabo) vs. Placebo With Cabozantinib (Pbo-Cabo) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination With Cabozantinib (CB-Cabo) vs. Placebo With Cabozantinib (Pbo-Cabo) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
Enrollment Status: Completed
Publish Date: March 20, 2023
Intervention Type: Drug
Study Drugs: CB-839, Cabozantinib
Study Phase: Phase 2
View 3 Less Clinical Trials

2 Total Publications

Rapid resolution of prostate cancer-related hemolytic uremic syndrome without plasma exchange - a case report.
Rapid resolution of prostate cancer-related hemolytic uremic syndrome without plasma exchange - a case report.
Journal: Hematology, transfusion and cell therapy
Published: July 31, 2018
Similar Doctors
Expertise in
19
conditions
Expertise in
19
conditions
Referral may be required

San Juan Oncology Associates PC

2325 E 30th St, 
Farmington, NM 
 (0.1 miles away)
505-564-6850
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jeffrey Neidhart is a Hematologist practicing medicine in Farmington, New Mexico. Dr. Neidhart is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Aplastic Anemia, Large-Cell Immunoblastic Lymphoma, Small Lymphocytic Lymphoma (SLL), Gastrostomy, and Endoscopy. Dr. Neidhart is currently accepting new patients.

Expertise in
6
conditions
Expertise in
6
conditions
Referral may be required

CommonSpirit Oncology Mercy

1 Mercado St Ste 100, 
Durango, CO 
 (50.6 miles away)
970-385-7977
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Elaine Kaime is a Hematologist practicing medicine in Durango, Colorado. Dr. Kaime is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Muscle Invasive Bladder Cancer, Polycythemia Vera, Richter Syndrome, and Chronic B-Cell Leukemia (CBCL). Dr. Kaime is currently accepting new patients.

Expertise in
0
conditions
Dr. Ankit Anand
Hematology
Expertise in
0
conditions
Dr. Ankit Anand
Hematology
Referral may be required

San Juan Oncology Associates PC

2325 E 30th St, 
Farmington, NM 
 (0.1 miles away)
505-564-6850
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ankit Anand is a Hematologist practicing medicine in Farmington, New Mexico. His clinical expertise encompasses RUNX1 Familial Platelet Disorder, Hemangioma Thrombocytopenia Syndrome, Multiple Myeloma, and Thrombocytopenia. Dr. Anand is currently accepting new patients.

Frequently Asked Questions about Dr. Sardar Z. Imam

How do I make an appointment with Dr. Sardar Z. Imam?

You can book an appointment with Dr. Sardar Z. Imam by calling their office at 505-564-6850. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Sardar Z. Imam a top-rated expert for Lung Nodules?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sardar Z. Imam is classified as an Advanced expert for Lung Nodules, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Sardar Z. Imam specialize in?

While Dr. Sardar Z. Imam is a Hematology, they have specific expertise in Lung Nodules, Multiple Myeloma, and Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Sardar Z. Imam participate in research or clinical trials?

Yes. Dr. Sardar Z. Imam has published 2 articles and abstracts on conditions like Lung Nodules. You can view a list of Dr. Sardar Z. Imam's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Sardar Z. Imam accept my insurance?

Dr. Sardar Z. Imam accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 505-564-6850 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Imam's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 50 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile